• 22330 Citations
  • 68 Scopus h-Index
1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where David William Dodick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Migraine Disorders Medicine & Life Sciences
Headache Medicine & Life Sciences
Headache Disorders Medicine & Life Sciences
Primary Headache Disorders Medicine & Life Sciences
Tryptamines Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Secondary Headache Disorders Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache

Kopruszinski, C. M., Navratilova, E., Vagnerova, B., Swiokla, J., Patwardhan, A., Dodick, D. W. & Porreca, F., Jan 1 2019, (Accepted/In press) In : Cephalalgia.

Research output: Contribution to journalArticle

Secondary Headache Disorders
Dronabinol
Cannabinoids
Sensory Thresholds
Cannabinoid Receptor Agonists
5 Citations (Scopus)
Calcitonin Gene-Related Peptide Receptors
Migraine Disorders
Monoclonal Antibodies
Calcitonin Gene-Related Peptide
Ligands

Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data

Dodick, D. W., Silberstein, S. D., Lipton, R. B., DeGryse, R. E., Adams, A. M. & Diener, H. C., Jan 1 2019, In : Cephalalgia.

Research output: Contribution to journalArticle

Migraine Disorders
Research
Headache
Placebos
Therapeutics

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches

Tepper, S. J., Dodick, D. W., Schmidt, P. C. & Kellerman, D. J., Jan 1 2019, In : Headache.

Research output: Contribution to journalArticle

Open Access
zolmitriptan
Migraine Disorders
Odds Ratio
Placebos
Pain
2 Citations (Scopus)

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial

Dodick, D. W., Lipton, R. B., Silberstein, S., Goadsby, P. J., Biondi, D., Hirman, J., Cady, R. & Smith, J., Jan 1 2019, In : Cephalalgia.

Research output: Contribution to journalArticle

Migraine Disorders
Clinical Trials
Placebos
Calcitonin Gene-Related Peptide
Age of Onset